Press Releases
 
Plasma Protease C1 Inhibitor Treatment Market is Expanding at a CAGR of 20.0% from 2017 to 2025

Transparency Market Research Report Added "Plasma Protease C1 Inhibitor Treatment Market" to its database.

Albany NY, 7 December 2018 -- Plasma Protease C1-inhibitor Treatment Market report categorizes the global market by Drug Class (C1-inhibitor, Kallikrein Inhibitor, Selective Bradykinin B2 Receptor Antagonist), Dosage Type, (Lyophilized and Liquid/Injectable), Distribution Channel & Geography

Global Plasma Protease C1-inhibitor Treatment Market: Snapshot

The global plasma protease C1-inhibitor treatment market is foreseen to display robust growth in the future due to the increasing cases of acute hereditary angioedema (HAE) and prophylaxis. The emergence of a few drug variants of C1-inhibitor is considered to be a major breakthrough for patients suffering from HAE that are administered either intravenously or subcutaneously.

According to a report by Transparency Market Research (TMR), the global plasma protease C1-inhibitor treatment market was evaluated at US$1.5 bn in 2016. The report forecasts the demand in the global plasma protease C1-inhibitor market will rise at a robust 20.0% CAGR for the forecast period of 2017 to 2025, for the market to be valued at US$7.9 bn by the end of 2025.

Extensive Use for HAE Makes C1-inhibitor Drug Class Dominant

Based on drug class, the global plasma protease C1-inhibitor market is classified into C1-inhibitor, Kallikrein inhibitor, and selective Bradykinin B2 receptor antagonist (Firazyr). The C1-inhibitor segment held the leading market share in 2016 as these drugs are widely used for the treatment of acute HAE and prophylaxis. The segment of Selective Bradykining B2 Receptor is anticipated to display the leading growth rate over the forecast period. This is mainly because of expanding R&D activities that key players are engaged in for the development of new C1-inhibitor deficiency drugs that can be administered subcutaneously. On the other hand, the segment of Kallikrein inhibitor (Kalbitor) is predicted to register a moderate CAGR between 2017 and 2025. The growth of Kallikrein inhibitor segment is attributable to the rising preference for self-administrable drugs. Moreover, the rising preference for Firazyr is anticipated to hamper the growth of Kalbitor segment. However, increasing approval of Kallikrein drugs and positive results obtained for pre-clinical treatment of HAE cases are likely to augment the growth rate of this segment moderately over the forecast period.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33116

On the basis of dosage type, the market is segregated into lyophilized and liquid/injectable. Of the two, lyophilized segment held the leading market share in 2016 on the back of increasing practice of intravenous administration of drugs for the treatment of HAE. Further, rising demand for intravenous C1 esterase inhibitor drugs in emerging markets of Asia Pacific and Latin America is anticipated to positively influence the lyophilized segment.

However, the liquid/injectable segment is likely to hold significant market share by 2025 due to several factors. This includes rising demand for subcutaneous administration of drugs, less adverse effects, cost effectiveness, and increased preference for Firazyr over Kalbitor by physicians. The expected launch of subcutaneous Cinryze, Berinert, and DX-2930 will further hamper the growth of lyophilized segment. To stay competitive, companies are vying to introduce the subcutaneous variants of Cinryze and Berinet for prophylactic treatment and are expected to be commercially available by 2019 and 2018 respectively. Despite the liquid/injectable nature of Firazyr and Kalbitor the side-effects associated with them can hamper the liquid/injectable segment over the forecast period.

In terms of distribution channel, the market has been bifurcated into hospital pharmacies and independent pharmacies & outlets in this report. Of the two, independent pharmacies & outlets dominated the market in 2016; the segment is anticipated to hold dominance through 2025.

North America to Lead Plasma Protease C1-inhibitor Treatment Market through 2025

Geographically, the plasma protease C1-inhibitor treatment market is divided into four key regions, namely North America, Europe, Latin America, and Rest of the World. Among these, North America stood as the leading contributor to the worldwide market for plasma protease C1-inhibitor treatment market in 2016. High prevalence of HAE in the U.S. that are actually diagnosed and treated using C1-inhibitor drugs account for the leading growth of this regional market.

The global plasma protease C1-inhibitor treatment market features a highly consolidated vendor landscape. Shire plc, Pharming Group N.V., CSL Limited, and Sanquin are the key companies operating in this market.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email:

Website: https://www.transparencymarketresearch.com

# # #


Submitted by hawer on Friday, 7 December 2018 at 2:39 PM
Category: Health Care & Medical
 
Related News

Bleeding Disorder Treatment Market Trends Shows a Rapid Growth by 2025
Tuesday, 19 Mar 2019

Fibromyalgia Treatment Market Will Generate New Growth Opportunities By 2027
Tuesday, 19 Mar 2019

Cell Free Protein Expression Market Size, Status and Forecast to 2026
Monday, 18 Mar 2019

Heart Attack Diagnostics Market to Observe Significant Growth during 2016-2024
Monday, 18 Mar 2019

Single-Dose Therapy Market Growth Impact and Demand by Regions
Monday, 18 Mar 2019

Related Events

Principles of Pain Management and Palliative Care 2019
Sunday, 17 Mar 2019

The 29th International Pediatric Association (IPA) Congress 2019
Sunday, 17 Mar 2019

21st Annual Superbugs & Superdrugs Conference
Monday, 18 Mar 2019

2nd Adaptive Clinical Trials Symposium
Monday, 18 Mar 2019

SMi's 3rd Annual Drug Discovery Chemistry
Monday, 18 Mar 2019

Latest News

Bleeding Disorder Treatment Market Trends Shows a Rapid Growth by 2025
Tuesday, 19 Mar 2019

The Advantages of Getting a Virtual Phone Number for the Organization
Tuesday, 19 Mar 2019

Fibromyalgia Treatment Market Will Generate New Growth Opportunities By 2027
Tuesday, 19 Mar 2019

Cell Free Protein Expression Market Size, Status and Forecast to 2026
Monday, 18 Mar 2019

Heart Attack Diagnostics Market to Observe Significant Growth during 2016-2024
Monday, 18 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 19 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • COMEX - IT Telecom And Technology Show 2019
  • Principles of Pain Management and Palliative Care 2019
  • The 29th International Pediatric Association (IPA) Congress 2019
  • 21st Annual Superbugs & Superdrugs Conference
  • 2nd Adaptive Clinical Trials Symposium

  • Latest Jobs
    Sorry, there are currently no entries posted here.